Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05594004 · ClinicalTrials.gov registry record
A Meta-analysis Comparing Toothbrushes on Plaque Removal and Gingival Health
A clinical trial of Gingivitis and Dental Plaque, sponsored by Procter and Gamble.
- Completed
- Registry status
- 2,929
- Enrollment target
- 1
- Study location
NCT05594004: Completed study of Gingivitis and Dental Plaque, sponsored by Procter and Gamble.
NCT05594004 is a study of Gingivitis and Dental Plaque that has completed, run by Procter and Gamble. The registered enrollment target is 2,929 participants, above the 120-participant average among 25 other Gingivitis trials with a reported enrollment target (2341% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05594004, a study of Gingivitis and Dental Plaque, has completed, sponsored by Procter and Gamble.
- COMPLETED
- Registry status
- 2,929 participants
- Enrollment target
- 1
- Study location
Study Summary
The aim of this analysis was to compare gingivitis- and plaque-reduction efficacy from randomized controlled trials (RCTs) up to six months long evaluating oscillating-rotating, sonic, and manual toothbrushes
Primary Outcome
Change from baseline as measured on number of bleeding sites ( via gingival bleeding index, Loe Silness index, Gingival Bleeding Index (GBI), Papillary bleeding index or Mazza gingival index).
Conditions Studied
Interventions
- DEVICE Manual toothbrush
- DEVICE Oscillating-rotating electric toothbrush
- DEVICE Sonic electric toothbrush
Study Locations (1)
Ohio
- Multiple Study Locations - Cincinnati
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,929 participants |
| Start Date | 2022-04-01 |
| Est. Completion | 2022-07-29 |
What the finished NCT05594004 record still lists
NCT05594004 is an observational study that tracks outcomes without assigning an intervention. Its 2,929 participants enrollment target places it among the larger protocols in the corpus, above the 120-participant average among 25 other Gingivitis trials with a reported enrollment target (2341% higher).
The record links to 2 conditions, with Gingivitis appearing as the primary indexed condition, and to 3 interventions - of which Manual toothbrush is the first listed.
NCT05594004 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT05594004 about?
NCT05594004 is a clinical study titled "A Meta-analysis Comparing Toothbrushes on Plaque Removal and Gingival Health". The aim of this analysis was to compare gingivitis- and plaque-reduction efficacy from randomized controlled trials (RCTs) up to six months long evaluating oscillating-rotating, sonic, and manual toothbrushes
What is the current status of trial NCT05594004?
This trial is currently completed. The enrollment target is 2,929 participants. The study started on 2022-04-01. Estimated completion is 2022-07-29.
What conditions does trial NCT05594004 study?
This clinical trial studies the following conditions: Gingivitis, Dental Plaque.
What interventions are being tested in trial NCT05594004?
The interventions under investigation include: Manual toothbrush (DEVICE), Oscillating-rotating electric toothbrush (DEVICE), Sonic electric toothbrush (DEVICE).
Who is sponsoring clinical trial NCT05594004?
This trial is sponsored by Procter and Gamble, which has 70 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05594004 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Gingivitis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05594004's enrollment target sits among peer trials
2,929 1st of 25 higher than 25 of 25 other Gingivitis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Gingivitis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Imaging-based Assessment of Oral Biofilm and Gingival Health
RECRUITING · NA
-
Extending Dental Care to Nursing Home Residents to Reduce Mouth Infections and Incidence of Pneumonia and Improve Diabetic Glucose Control
RECRUITING · NA
-
A Clinical Study to Evaluate the Effectiveness of an Experimental Toothpaste in Improving Gum Health and Reducing Plaque Accumulation
RECRUITING · NA
-
Effectiveness of Dual Light Electric Toothbrush vs. Manual Toothbrush in Orthodontic Patients Undergoing Oral Surgery
RECRUITING · NA
-
Variation in Gingival Inflammatory Responses
RECRUITING · NA
-
Assessing Gingivitis and Plaque From a Marketed Toothpaste
ACTIVE NOT RECRUITING · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05849961 · 2,946 participants
Exactech Hip Systems Post-Market Clinical Follow-up (PMCF)
- NCT03331380 · 2,950 participants · NA
Technical Development of Cardiovascular Magnetic Resonance Imaging (CMR) Using a Low Specific Absorption Rate (SAR) Scanner System
- NCT05564377 · 2,900 participants · Phase 2
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
- NCT07222995 · 2,900 participants · NA
Hybrid Effectiveness-Implementation Trial to Integrate Precision Skin Cancer Risk Feedback in FQHCs
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI